Skip to main content

MoneyWorks4Me

Concord Drugs informs about quarterly statement on investor complaints

21 Jan 2017 Evaluate

Concord Drugs has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1886.80
Dr. Reddys Labs. 1386.00
Cipla 1410.00
Lupin 2014.00
Zydus Lifesciences 1205.50
View more..